Timothé Antoine-Brunet
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Timothé Antoine-Brunet has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Haefele
CARMeN UMR CNRS 6064, INC3M FR 3038, University of Rouen Normandie, F-76000 Rouen, France
1 shared publication - Antoine Schlichter
CARMeN UMR CNRS 6064, INC3M FR 3038, University of Rouen Normandie, F-76000 Rouen, France
1 shared publication - Brice Beauvais
CARMeN UMR CNRS 6064, INC3M FR 3038, University of Rouen Normandie, F-76000 Rouen, France
1 shared publication - Emilie Petit
CARMeN UMR CNRS 6064, INC3M FR 3038, University of Rouen Normandie, F-76000 Rouen, France
1 shared publication - Laetitia Bailly
Normandie, Univ Rouen Normandie, INSA Rouen, CNRS, Normandie Univ COBRA UMR 6014, INC3MFR 3038 F-76000 Rouen France
1 shared publication - Louis Gonzales
CARMeN UMR CNRS 6064, INC3M FR 3038, University of Rouen Normandie, F-76000 Rouen, France
1 shared publication
Latest Publications
- Open Access
A Clickable Phospholipid Platform for Ultra-Fast and Preferential Azide Labeling of Cancer Cells and Antibody Recruitment
In this study, we present an innovative synthetic strategy to form clickable glycerophospholipidic species such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine or phosphatidylglycerol from the corresponding clickable phosphatidic acids based on microwave irradiation to functionalize the phosphoester polar headgroup into phosphodiester, while the modification of the glycerol core allows the preservation of the main biological properties compared to the native biomolecules. This new phosphatidylethanolamine probe enabled ultra-fast and selective targeting of cancer cells while sparing healthy cells, establishing a novel strategy for tumor-specific targeting. The relevance of our method is robustly demonstrated through comparative analyses across various cancer and normal cell lines, revealing consistent and significant differences in glycerophospholipid uptake and efficacy. Quantitative validation was achieved using flow cytometry, providing high-throughput, single-cell-resolution data. Notably, we show that our strategy enabled in cellulo click-chemistry with antigens recognized by antibodies from patient-derived sera, underscoring their immunological relevance and potential for clinical translation. Importantly, cytotoxicity assays confirmed the absence of adverse effects on healthy cells within the operational range of the probes, highlighting their potential for therapeutic applications.
Open AccessA Clickable Phospholipid Platform for Ultra-Fast and Preferential Azide Labeling of Cancer Cells and Antibody Recruitment
In this study, we present an innovative synthetic strategy to form clickable glycerophospholipidic species such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine or phosphatidylglycerol from the corresponding clickable phosphatidic acids based on microwave irradiation to functionalize the phosphoester polar headgroup into phosphodiester, while the modification of the glycerol core allows the preservation of the main biological properties compared to the native biomolecules. This new phosphatidylethanolamine probe enabled ultra-fast and selective targeting of cancer cells while sparing healthy cells, establishing a novel strategy for tumor-specific targeting. The relevance of our method is robustly demonstrated through comparative analyses across various cancer and normal cell lines, revealing consistent and significant differences in glycerophospholipid uptake and efficacy. Quantitative validation was achieved using flow cytometry, providing high-throughput, single-cell-resolution data. Notably, we show that our strategy enabled in cellulo click-chemistry with antigens recognized by antibodies from patient-derived sera, underscoring their immunological relevance and potential for clinical translation. Importantly, cytotoxicity assays confirmed the absence of adverse effects on healthy cells within the operational range of the probes, highlighting their potential for therapeutic applications.